Skip to main content
Accessibility.com, LLC
a promotional graphic telling you that PCI Compliance is no longer an annual exercise and that continuous monitory must be built in

LUIS LICEA v. IMMUNIC, INC.

Filed March 3, 2022

Plaintiff

  • Name: LUIS LICEA
  • Filing date: March 3, 2022
  • State of filing: California

Defendant

  • Name: IMMUNIC, INC.
  • Website: www.ir.imux.com
  • Industry: Pharmaceuticals, Biotechnology & Life Sciences
  • Summary: Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases.

Case Summary

On March 3, 2022, LUIS LICEA filed a complaint in California against IMMUNIC, INC.. Plaintiff LUIS LICEA alleges that www.ir.imux.com is not sufficiently digitally accessible.

Company Summary

Immunic Therapeutics was founded in 2016 and is headquartered in
1200 Avenue of the Americas 200, New York, NY 10036-1603, US.
It is in the Biotechnology industry and the website is imux.com.

Accessibility Overlays

A scan for 3rd Party Overlays was performed on March 11, 2022 and none were detected.

CaliforniaPharmaceuticals, Biotechnology & Life Sciences

Application Security Isn’t Optional Anymore.